Teyi Pharmaceutical Group Co Ltd Cash Flow Conversion Efficiency

Latest as of December 2025: 0.029x

Teyi Pharmaceutical Group Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Teyi Pharmaceutical Group Co Ltd (002728) has a cash flow conversion efficiency ratio of 0.029x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥52.94 Million ≈ $7.75 Million USD) by net assets (CN¥1.84 Billion ≈ $269.06 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Teyi Pharmaceutical Group Co Ltd (2009–2025)

Cash flow conversion efficiency of Teyi Pharmaceutical Group Co Ltd from 2009 to 2025. This chart illustrates how Teyi Pharmaceutical Group Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View 002728 stock price for real-time trading data and today's change.

Teyi Pharmaceutical Group Co Ltd Cash Flow Conversion Ratio Explained

Teyi Pharmaceutical Group Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Teyi Pharmaceutical Group Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Teyi Pharmaceutical Group Co Ltd ranked by their cash flow conversion efficiency. Also see how much is Teyi Pharmaceutical Group Co Ltd worth for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Oneness Biotech Co Ltd TWO:4743	-0.012x
Manitowoc Company Inc NYSE:MTW	0.011x
Udemy Inc NASDAQ:UDMY	0.074x
Midland States Bancorp, Inc. NASDAQ:MSBI	0.052x
Vats Liquor Chain Store Management Joint Stock Co Ltd SHE:300755	0.146x
DAKOTA GOLD CORP. DL-001 F:RR6	-0.040x
Dark Horse Beijing Technology Co Ltd SHE:300688	-0.034x
Naphtha TA:NFTA	0.097x

Annual Cash Flow Conversion Efficiency for Teyi Pharmaceutical Group Co Ltd (2009–2025)

The table below shows the annual cash flow conversion efficiency of Teyi Pharmaceutical Group Co Ltd from 2009 to 2025. Review Teyi Pharmaceutical Group Co Ltd free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥1.84 Billion ≈ $269.06 Million	CN¥244.88 Million ≈ $35.83 Million	0.133x	+1142.38%
2024-12-31	CN¥1.76 Billion ≈ $258.27 Million	CN¥-22.55 Million ≈ $-3.30 Million	-0.013x	-112.94%
2023-12-31	CN¥2.01 Billion ≈ $294.23 Million	CN¥198.56 Million ≈ $29.06 Million	0.099x	-62.72%
2022-12-31	CN¥1.40 Billion ≈ $205.32 Million	CN¥371.66 Million ≈ $54.39 Million	0.265x	+30.13%
2021-12-31	CN¥1.26 Billion ≈ $184.62 Million	CN¥256.81 Million ≈ $37.58 Million	0.204x	+30.14%
2020-12-31	CN¥1.08 Billion ≈ $158.10 Million	CN¥168.99 Million ≈ $24.73 Million	0.156x	-18.63%
2019-12-31	CN¥1.15 Billion ≈ $168.73 Million	CN¥221.64 Million ≈ $32.43 Million	0.192x	+13.64%
2018-12-31	CN¥1.11 Billion ≈ $162.60 Million	CN¥187.97 Million ≈ $27.51 Million	0.169x	+71.34%
2017-12-31	CN¥1.04 Billion ≈ $152.60 Million	CN¥102.96 Million ≈ $15.07 Million	0.099x	-13.59%
2016-12-31	CN¥886.57 Million ≈ $129.73 Million	CN¥101.30 Million ≈ $14.82 Million	0.114x	+33.44%
2015-12-31	CN¥804.30 Million ≈ $117.69 Million	CN¥68.87 Million ≈ $10.08 Million	0.086x	+9.84%
2014-12-31	CN¥735.64 Million ≈ $107.65 Million	CN¥57.35 Million ≈ $8.39 Million	0.078x	-63.23%
2013-12-31	CN¥350.14 Million ≈ $51.24 Million	CN¥74.23 Million ≈ $10.86 Million	0.212x	-42.12%
2012-12-31	CN¥285.34 Million ≈ $41.75 Million	CN¥104.50 Million ≈ $15.29 Million	0.366x	+18.31%
2011-12-31	CN¥225.51 Million ≈ $33.00 Million	CN¥69.81 Million ≈ $10.21 Million	0.310x	+12.70%
2010-12-31	CN¥170.81 Million ≈ $25.00 Million	CN¥46.92 Million ≈ $6.87 Million	0.275x	+26.99%
2009-12-31	CN¥103.18 Million ≈ $15.10 Million	CN¥22.32 Million ≈ $3.27 Million	0.216x	--

About Teyi Pharmaceutical Group Co Ltd

SHE:002728 China Drug Manufacturers - Specialty & Generic

Market Cap

$675.27 Million

CN¥4.61 Billion CNY

Market Cap Rank

#10364 Global

#2707 in China

Share Price

CN¥8.99

Change (1 day)

+0.90%

52-Week Range

CN¥8.00 - CN¥15.21

All Time High

CN¥129.24